A172細胞 
	
		器官來源:	大腦
	
	
		是否是腫瘤細胞:	1
	
	
		物種來源:	人
	
	
		生長狀態:	貼壁生長
	
	
		運輸方式:	凍存運輸
	
	
		ATCC Number:	CRL-1620?
	
	
		相關**:	其他**
	
	
		年限:	53 years
	
	
		數量:	大量
	
	
		Designations:	A-172 [A172]
	
	
		Depositors:	 DJ Giard
	
	
		A172細胞Biosafety Level:	1
	
	
		Shipped:	frozen
	
	
		Medium & Serum:	See Propagation
	
	
		Growth Properties:	adherent
	
	
		Organism:	Homo sapiens
	
	
		Morphology:
	
	
		Source:	Organ: brain
	
	
		Disease: glioblastoma
	
	
		Permits/Forms:	In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
	
	
		Tumorigenic:	No
	
	
		DNA Profile (STR): A172細胞Amelogenin: X,Y
	
	
		CSF1PO: 9,12
	
	
		D13S317: 11
	
	
		D16S539: 12
	
	
		D5S818: 11,12
	
	
		D7S820: 11
	
	
		THO1: 6,9.3
	
	
		TPOX: 8,11
	
	
		vWA: 20
	
	
		Age:	53 years
	
	
		Gender:	male
	
	
		Propagation: A172細胞ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Dulbecco's Modified Eagle's Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
	
	
		Temperature: 37.0°C
	
	
		Subculturing:	Protocol: Remove medium, and rinse with 0.25% trypsin, 0.03% EDTA solution. Remove the solution and add an additional 1 to 2 ml of trypsin-EDTA solution. Allow the flask to sit at room temperature (or at 37C) until the cells detach. Add fresh culture medium, aspirate and dispense into new culture flasks.
	
	
		Subcultivation Ratio: A subcultivation ratio of 1:3 to 1:8 is recommended
	
	
		Medium Renewal: Every 2 to 3 days
	
	
		Preservation:	Freeze medium: culture medium 95%; DMSO, 5%
	
	
		Storage temperature: liquid nitrogen vapor phase
	
	
		Related Products: A172細胞Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2002
	
	
		recommended serum:ATCC 30-2020
	
	
		References:	23094: Olopade OI, et al. Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas. Cancer Res. 52: 2523-2529, 1992. PubMed: 1568221
	
	
		23218: Giard DJ, et al. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J. Natl. Cancer Inst. 51: 1417-1423, 1973. PubMed: 4357758
	
	
		32550: Debinski W, et al. Receptor for interleukin (IL) 13 does not interact with IL4 but receptor for IL4 interacts with IL13 on human glioma cells. J. Biol. Chem. 271: 22428-22433, 1996. A172細胞PubMed: 8798406